R J Coker

2.5k total citations
67 papers, 1.6k citations indexed

About

R J Coker is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, R J Coker has authored 67 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Infectious Diseases, 37 papers in Epidemiology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in R J Coker's work include Tuberculosis Research and Epidemiology (21 papers), Pneumocystis jirovecii pneumonia detection and treatment (17 papers) and Pneumonia and Respiratory Infections (10 papers). R J Coker is often cited by papers focused on Tuberculosis Research and Epidemiology (21 papers), Pneumocystis jirovecii pneumonia detection and treatment (17 papers) and Pneumonia and Respiratory Infections (10 papers). R J Coker collaborates with scholars based in United Kingdom, Singapore and Thailand. R J Coker's co-authors include Sandra Mounier‐Jack, Marco Liverani, James W. Rudge, Piya Hanvoravongchai, Benjamin M. Hunter, Rifat Atun, Martin McKee, David M. Mitchell, J R Harris and Alma J Adler and has published in prestigious journals such as The Lancet, PLoS ONE and Environmental Health Perspectives.

In The Last Decade

R J Coker

65 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R J Coker United Kingdom 19 850 618 326 229 170 67 1.6k
Jon Kim Andrus United States 36 1.3k 1.5× 1.3k 2.1× 312 1.0× 168 0.7× 123 0.7× 115 3.0k
Silvia Declich Italy 30 1.1k 1.3× 822 1.3× 554 1.7× 373 1.6× 143 0.8× 105 2.4k
Richard Coker United Kingdom 27 987 1.2× 1.0k 1.7× 461 1.4× 325 1.4× 211 1.2× 111 2.4k
G Garnett United Kingdom 23 760 0.9× 813 1.3× 209 0.6× 610 2.7× 101 0.6× 41 1.8k
Ralf Reintjes Germany 23 453 0.5× 451 0.7× 225 0.7× 150 0.7× 92 0.5× 82 1.6k
Jennifer B. Nuzzo United States 22 466 0.5× 395 0.6× 155 0.5× 262 1.1× 159 0.9× 86 1.5k
Lisa D. Rotz United States 18 729 0.9× 711 1.2× 340 1.0× 144 0.6× 98 0.6× 25 2.2k
J. Peter Figueroa Jamaica 24 691 0.8× 427 0.7× 170 0.5× 414 1.8× 76 0.4× 93 1.9k
David L. Blazes United States 23 577 0.7× 588 1.0× 496 1.5× 131 0.6× 30 0.2× 69 1.8k
Godfrey Musuka Zimbabwe 22 760 0.9× 317 0.5× 221 0.7× 338 1.5× 203 1.2× 148 1.6k

Countries citing papers authored by R J Coker

Since Specialization
Citations

This map shows the geographic impact of R J Coker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R J Coker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R J Coker more than expected).

Fields of papers citing papers by R J Coker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R J Coker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R J Coker. The network helps show where R J Coker may publish in the future.

Co-authorship network of co-authors of R J Coker

This figure shows the co-authorship network connecting the top 25 collaborators of R J Coker. A scholar is included among the top collaborators of R J Coker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R J Coker. R J Coker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Mishal, et al.. (2017). Risk factors that may be driving the emergence of drug resistance in tuberculosis patients treated in Yangon, Myanmar. PLoS ONE. 12(6). e0177999–e0177999. 8 indexed citations
2.
Tun, Zaw Myo, Mahesh Moorthy, Martin Linster, et al.. (2016). Characteristics of acute febrile illness and determinants of illness recovery among adults presenting to Singapore primary care clinics. BMC Infectious Diseases. 16(1). 612–612. 9 indexed citations
3.
Lover, Andrew A. & R J Coker. (2014). Re-assessing the relationship between sporozoite dose and incubation period in Plasmodium vivax malaria: a systematic re-analysis. Parasitology. 141(6). 859–868. 1 indexed citations
4.
Shigayeva, Altynay & R J Coker. (2014). Communicable disease control programmes and health systems: an analytical approach to sustainability. Health Policy and Planning. 30(3). 368–385. 45 indexed citations
5.
Coker, R J, Benjamin M. Hunter, James W. Rudge, Marco Liverani, & Piya Hanvoravongchai. (2011). Emerging infectious diseases in southeast Asia: regional challenges to control. The Lancet. 377(9765). 599–609. 324 indexed citations
6.
Coker, R J, Sandra Mounier‐Jack, & Robyn Martin. (2007). Public health law and tuberculosis control in Europe. Public Health. 121(4). 266–273. 18 indexed citations
7.
Atun, Rifat, Reda Lebcir, Martin McKee, Jarno Habicht, & R J Coker. (2006). Impact of joined-up HIV harm reduction and multidrug resistant tuberculosis control programmes in Estonia: System dynamics simulation model. Health Policy. 81(2-3). 207–217. 37 indexed citations
8.
Mounier‐Jack, Sandra & R J Coker. (2006). How prepared is Europe for pandemic influenza? Analysis of national plans. The Lancet. 367(9520). 1405–1411. 137 indexed citations
9.
Atun, Rifat, Yevgeniy Samyshkin, Francis Drobniewski, et al.. (2005). Seasonal variation and hospital utilization for tuberculosis in Russia: hospitals as social care institutions. European Journal of Public Health. 15(4). 350–354. 41 indexed citations
10.
Atun, Rifat, Reda Lebcir, Francis Drobniewski, & R J Coker. (2005). Impact of an effective multidrug-resistant tuberculosis control programme in the setting of an immature HIV epidemic: system dynamics simulation model. International Journal of STD & AIDS. 16(8). 560–570. 29 indexed citations
11.
Marshall, Ben G., et al.. (1999). HIV and tuberculosis co-infection in an inner London Hospital— a prospective anonyrnized seroprevalence study. Journal of Infection. 38(3). 162–166. 16 indexed citations
12.
Coker, R J, Martin Fisher, & David R. Tomlinson. (1995). Management of Mycoses Associated with HIV Disease. International Journal of STD & AIDS. 6(6). 408–412. 9 indexed citations
13.
Coker, R J, N Desmond, Mark C. Poznansky, et al.. (1995). Experience of HIV Disease in a London District General Hospital. International Journal of STD & AIDS. 6(1). 47–49. 2 indexed citations
14.
Ferris, John D., et al.. (1995). Screening for cytomegalovirus retinitis in HIV-positive and AIDS patients. QJM. 88(12). 899–903. 1 indexed citations
15.
Desmond, N, et al.. (1994). Schistosomiasis: an unusual cause of pruritus vulvae. Journal of the European Academy of Dermatology and Venereology. 3(2). 206–208. 2 indexed citations
16.
Nieman, Richard, J. T. Fleming, R J Coker, J R Harris, & David M. Mitchell. (1993). The effect of cigarette smoking on the development of AIDS in HIV-1-seropositive individuals. AIDS. 7(5). 705–710. 91 indexed citations
17.
Coker, R J, M. A. Viviani, Brian Gazzard, et al.. (1993). Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS. AIDS. 7(6). 829–836. 88 indexed citations
18.
Coker, R J, et al.. (1992). Cavitating pulmonary cryptococcosis developing in an HIV antibody patient despite prior treatment with fluconazole.. Sexually Transmitted Infections. 68(1). 42–44. 3 indexed citations
19.
Tomlinson, David R., R J Coker, Sheridan Waldron, & J R Harris. (1991). Early Aggressive Management of Cryptosporidial Infection in AIDS. International Journal of STD & AIDS. 2(3). 202–203. 1 indexed citations
20.
Coker, R J. (1990). Pelvic inflammatory disease. BMJ. 300(6736). 1400.5–1400.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jon Kim Andrus Breakdown of academic impact, for papers by Silvia Declich Breakdown of academic impact, for papers by Richard Coker Breakdown of academic impact, for papers by G Garnett Breakdown of academic impact, for papers by Ralf Reintjes Breakdown of academic impact, for papers by Jennifer B. Nuzzo Breakdown of academic impact, for papers by Lisa D. Rotz Breakdown of academic impact, for papers by J. Peter Figueroa Breakdown of academic impact, for papers by David L. Blazes Breakdown of academic impact, for papers by Godfrey Musuka
Rankless by CCL
2026